110 related articles for article (PubMed ID: 3294401)
1. Evolution of beta-lactamase inhibitors.
Rolinson GN
J Reprod Med; 1988 Jun; 33(6 Suppl):571-3. PubMed ID: 3294401
[TBL] [Abstract][Full Text] [Related]
2. Development of beta-lactamase inhibitors.
Sutherland R
J Reprod Med; 1990 Mar; 35(3 Suppl):307-12. PubMed ID: 2319512
[TBL] [Abstract][Full Text] [Related]
3. Evolution of beta-lactamase inhibitors.
Rolinson GN
Surg Gynecol Obstet; 1991; 172 Suppl():11-6. PubMed ID: 2024221
[TBL] [Abstract][Full Text] [Related]
4. Parenteral beta-lactamase inhibitor combinations for clinical use.
Manzella JP
Am Fam Physician; 1995 May; 51(7):1695-8. PubMed ID: 7754928
[TBL] [Abstract][Full Text] [Related]
5. Evolution of beta-lactamase inhibitors.
Jackson D
Pharmacotherapy; 1991; 11(2 ( Pt 2)):37S-39S. PubMed ID: 2041830
[TBL] [Abstract][Full Text] [Related]
6. Potentiation of human polymorphonuclear leukocyte phagocytosis and intracellular bactericidal activity by amoxycillin/clavulanic acid.
Cuffini AM; De Renzi G; Tullio V; Paizis G; Carlone NA
Drugs Exp Clin Res; 1996; 22(1):9-15. PubMed ID: 8839632
[TBL] [Abstract][Full Text] [Related]
7. Effect of beta-lactamase inhibitors on minimum inhibitory concentration of ampicillin and amoxicillin for Staphylococcus aureus strains.
Paniagua GL; Monroy E; García O; Vaca S
Rev Latinoam Microbiol; 1998; 40(3-4):128-34. PubMed ID: 10932741
[TBL] [Abstract][Full Text] [Related]
8. Effect of ticarcillin and ticarcillin/clavulanic acid on the in-vitro activity of human granulocytes against beta-lactamase-producing Klebsiella pneumoniae.
Cuffini AM; de Renzi G; Tullio V; Paizis G; Carlone NA
Int J Tissue React; 1995; 17(5-6):199-203. PubMed ID: 8835630
[TBL] [Abstract][Full Text] [Related]
9. Bacteriological investigations with beta-lactamase inhibitors.
Ullmann U
Zentralbl Bakteriol Mikrobiol Hyg A Med Mikrobiol Infekt Parasitol; 1982 Jun; 252(2):222-9. PubMed ID: 6289565
[TBL] [Abstract][Full Text] [Related]
10. [Beta-lactamase inhibitors].
Gialdroni Grassi G
G Ital Chemioter; 1982; 29(1):1-10. PubMed ID: 6764431
[No Abstract] [Full Text] [Related]
11. [In vitro study of the effects of a ticarcillin-clavulanic acid combination on Pseudomonas aeruginosa as a function of resistant phenotypes].
Thabaut A; Meyran M
Pathol Biol (Paris); 1985 May; 33(5):408-11. PubMed ID: 3929218
[TBL] [Abstract][Full Text] [Related]
12. Evaluation in an animal model and in vitro of the combination clavulanic acid and cephalosporins against beta-lactamase producing and nonproducing Staphylococcus aureus strains.
de Sá Del Fiol F; Rocha De Mattos Filho T; Groppo FC
Braz J Infect Dis; 2000 Feb; 4(1):36-42. PubMed ID: 10788844
[TBL] [Abstract][Full Text] [Related]
13. The incidence of beta-lactamase-producing pathogens.
Acar JF; Kitzis MD; Gutmann L
APMIS Suppl; 1989; 5():2-8. PubMed ID: 2660867
[TBL] [Abstract][Full Text] [Related]
14. Structure-based enhancement of boronic acid-based inhibitors of AmpC beta-lactamase.
Weston GS; Blázquez J; Baquero F; Shoichet BK
J Med Chem; 1998 Nov; 41(23):4577-86. PubMed ID: 9804697
[TBL] [Abstract][Full Text] [Related]
15. Comparative evaluation of the in vitro activity of three combinations of beta-lactams with beta-lactamase inhibitors: piperacillin/tazobactam, ticarcillin/clavulanic acid and ampicillin/sulbactam.
Sader HS; Tosin I; Sejas L; Miranda E
Braz J Infect Dis; 2000 Feb; 4(1):22-8. PubMed ID: 10788842
[TBL] [Abstract][Full Text] [Related]
16. [Detection of hyperproduction of chromosomal beta-lactamase in strains of Escherichia coli, Enterobacter cloacae and Pseudomonas aeruginosa].
Roy C; Tirado M; Segura C; Esteva C; Teruel D
Enferm Infecc Microbiol Clin; 1989; 7(6):301-6. PubMed ID: 2518766
[TBL] [Abstract][Full Text] [Related]
17. Trends in the development of beta-lactam antibiotics.
Neu HC
Scand J Infect Dis Suppl; 1984; 42():7-16. PubMed ID: 6597563
[TBL] [Abstract][Full Text] [Related]
18. Implications of beta-lactamase-inhibitor combinations.
Jones RN
J Reprod Med; 1988 Jun; 33(6 Suppl):574-8. PubMed ID: 3294402
[TBL] [Abstract][Full Text] [Related]
19. Multidrug-resistant bacteria in hospitalized children: a 5-year multicenter study.
Raymond J; Nordmann P; Doit C; Vu Thien H; Guibert M; Ferroni A; Aujard Y
Pediatrics; 2007 Apr; 119(4):e798-803. PubMed ID: 17403822
[TBL] [Abstract][Full Text] [Related]
20. beta-Lactamase activity in mycobacteria including Mycobacterium avium and suppression of their growth by a beta-lactamase-stable antibiotic.
Prabhakaran K; Harris EB; Randhawa B; Hastings RC
Microbios; 1995; 81(328):177-85. PubMed ID: 7752957
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
